nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—schizophrenia	0.614	1	CbGaD
Pranlukast—RNASE3—blood plasma—schizophrenia	0.0178	0.144	CbGeAlD
Pranlukast—MUC2—forebrain—schizophrenia	0.00681	0.0551	CbGeAlD
Pranlukast—RNASE3—blood—schizophrenia	0.00653	0.0527	CbGeAlD
Pranlukast—MUC2—telencephalon—schizophrenia	0.00627	0.0506	CbGeAlD
Pranlukast—IL5—blood—schizophrenia	0.00593	0.0479	CbGeAlD
Pranlukast—MUC2—gonad—schizophrenia	0.00523	0.0423	CbGeAlD
Pranlukast—IL5—endocrine gland—schizophrenia	0.00514	0.0415	CbGeAlD
Pranlukast—TNF—blood—schizophrenia	0.00456	0.0368	CbGeAlD
Pranlukast—MUC2—endocrine gland—schizophrenia	0.00395	0.0319	CbGeAlD
Pranlukast—NFKB1—forebrain—schizophrenia	0.00389	0.0314	CbGeAlD
Pranlukast—MUC2—nervous system—schizophrenia	0.0037	0.0299	CbGeAlD
Pranlukast—NFKB1—telencephalon—schizophrenia	0.00357	0.0289	CbGeAlD
Pranlukast—MUC2—central nervous system—schizophrenia	0.00356	0.0288	CbGeAlD
Pranlukast—CYP2C9—urine—schizophrenia	0.00355	0.0287	CbGeAlD
Pranlukast—MUC2—cerebellum—schizophrenia	0.00348	0.0281	CbGeAlD
Pranlukast—NFKB1—gonad—schizophrenia	0.00298	0.0241	CbGeAlD
Pranlukast—MUC2—brain—schizophrenia	0.00283	0.0228	CbGeAlD
Pranlukast—CYP3A4—urine—schizophrenia	0.00271	0.0219	CbGeAlD
Pranlukast—NFKB1—blood—schizophrenia	0.0026	0.021	CbGeAlD
Pranlukast—CYSLTR1—blood—schizophrenia	0.00255	0.0206	CbGeAlD
Pranlukast—NFKB1—endocrine gland—schizophrenia	0.00225	0.0182	CbGeAlD
Pranlukast—CYSLTR1—endocrine gland—schizophrenia	0.00221	0.0179	CbGeAlD
Pranlukast—NFKB1—nervous system—schizophrenia	0.00211	0.017	CbGeAlD
Pranlukast—CYSLTR1—nervous system—schizophrenia	0.00207	0.0167	CbGeAlD
Pranlukast—NFKB1—central nervous system—schizophrenia	0.00203	0.0164	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—schizophrenia	0.00199	0.0161	CbGeAlD
Pranlukast—NFKB1—cerebellum—schizophrenia	0.00198	0.016	CbGeAlD
Pranlukast—Ospemifene—ESR1—schizophrenia	0.0019	0.725	CrCbGaD
Pranlukast—CYP2C9—blood plasma—schizophrenia	0.00186	0.015	CbGeAlD
Pranlukast—NFKB1—brain—schizophrenia	0.00161	0.013	CbGeAlD
Pranlukast—CYSLTR1—brain—schizophrenia	0.00158	0.0128	CbGeAlD
Pranlukast—CYP3A4—blood plasma—schizophrenia	0.00141	0.0114	CbGeAlD
Pranlukast—ABCC2—blood—schizophrenia	0.00102	0.00824	CbGeAlD
Pranlukast—ABCC2—endocrine gland—schizophrenia	0.000885	0.00715	CbGeAlD
Pranlukast—Candesartan—ABCB1—schizophrenia	0.000721	0.275	CrCbGaD
Pranlukast—CYP2C9—blood—schizophrenia	0.00068	0.00549	CbGeAlD
Pranlukast—CYP2C9—endocrine gland—schizophrenia	0.000589	0.00476	CbGeAlD
Pranlukast—CYP3A4—blood—schizophrenia	0.000518	0.00419	CbGeAlD
Pranlukast—CYP3A4—endocrine gland—schizophrenia	0.000449	0.00363	CbGeAlD
Pranlukast—CYP3A4—nervous system—schizophrenia	0.000421	0.0034	CbGeAlD
Pranlukast—CYP3A4—central nervous system—schizophrenia	0.000405	0.00327	CbGeAlD
Pranlukast—NFKB1—Signaling Pathways—RGS4—schizophrenia	4.41e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRG1—schizophrenia	4.4e-05	0.000169	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—schizophrenia	4.38e-05	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—schizophrenia	4.37e-05	0.000168	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NTRK2—schizophrenia	4.36e-05	0.000167	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	4.35e-05	0.000167	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD3—schizophrenia	4.34e-05	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR6—schizophrenia	4.33e-05	0.000167	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PLA2G4A—schizophrenia	4.32e-05	0.000166	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	4.3e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB3—schizophrenia	4.29e-05	0.000165	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—schizophrenia	4.28e-05	0.000165	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—schizophrenia	4.25e-05	0.000163	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRG1—schizophrenia	4.25e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—YWHAZ—schizophrenia	4.21e-05	0.000162	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD4—schizophrenia	4.21e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MEF2C—schizophrenia	4.21e-05	0.000162	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—schizophrenia	4.2e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—COMT—schizophrenia	4.19e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAG—schizophrenia	4.18e-05	0.000161	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTP1—schizophrenia	4.17e-05	0.00016	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—MAOA—schizophrenia	4.16e-05	0.00016	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	4.14e-05	0.000159	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—schizophrenia	4.13e-05	0.000159	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB3—schizophrenia	4.12e-05	0.000158	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	4.12e-05	0.000158	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.1e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—EP300—schizophrenia	4.09e-05	0.000157	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—YWHAZ—schizophrenia	4.07e-05	0.000156	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	4.04e-05	0.000155	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—schizophrenia	4.03e-05	0.000155	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CNR1—schizophrenia	4.02e-05	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—schizophrenia	4.01e-05	0.000154	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB3—schizophrenia	3.98e-05	0.000153	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR7—schizophrenia	3.92e-05	0.000151	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD2—schizophrenia	3.92e-05	0.000151	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MEF2C—schizophrenia	3.92e-05	0.000151	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—schizophrenia	3.87e-05	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	3.86e-05	0.000149	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTM1—schizophrenia	3.83e-05	0.000147	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—schizophrenia	3.83e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CHRM1—schizophrenia	3.83e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	3.79e-05	0.000146	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	3.78e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—GSK3B—schizophrenia	3.77e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL3RA—schizophrenia	3.73e-05	0.000143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRL—schizophrenia	3.7e-05	0.000142	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	3.65e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TLE1—schizophrenia	3.64e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRG3—schizophrenia	3.64e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-E—schizophrenia	3.63e-05	0.000139	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—schizophrenia	3.61e-05	0.000139	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	3.6e-05	0.000138	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GFAP—schizophrenia	3.6e-05	0.000138	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PRODH—schizophrenia	3.59e-05	0.000138	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—schizophrenia	3.57e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRM5—schizophrenia	3.56e-05	0.000137	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—schizophrenia	3.56e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—schizophrenia	3.55e-05	0.000136	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOA1—schizophrenia	3.52e-05	0.000135	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—schizophrenia	3.51e-05	0.000135	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—S100B—schizophrenia	3.45e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TLE3—schizophrenia	3.45e-05	0.000132	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—schizophrenia	3.41e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—schizophrenia	3.4e-05	0.000131	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ESR1—schizophrenia	3.4e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—GSK3B—schizophrenia	3.33e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FOS—schizophrenia	3.3e-05	0.000127	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB4—schizophrenia	3.3e-05	0.000127	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	3.3e-05	0.000127	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	3.3e-05	0.000127	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.28e-05	0.000126	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	3.25e-05	0.000125	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCK—schizophrenia	3.25e-05	0.000125	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRL—schizophrenia	3.24e-05	0.000125	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.2e-05	0.000123	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—schizophrenia	3.2e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—GSK3B—schizophrenia	3.19e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE4B—schizophrenia	3.17e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—schizophrenia	3.15e-05	0.000121	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—schizophrenia	3.15e-05	0.000121	CbGpPWpGaD
Pranlukast—IL5—Immune System—EP300—schizophrenia	3.14e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCKAR—schizophrenia	3.12e-05	0.00012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLA2G4A—schizophrenia	3.1e-05	0.000119	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GSK3B—schizophrenia	3.08e-05	0.000118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRG1—schizophrenia	3.05e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADORA2A—schizophrenia	3.03e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—S100B—schizophrenia	3.02e-05	0.000116	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MEF2C—schizophrenia	3.02e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—schizophrenia	2.93e-05	0.000113	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MPC2—schizophrenia	2.92e-05	0.000112	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—YWHAZ—schizophrenia	2.92e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGA—schizophrenia	2.9e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB4—schizophrenia	2.89e-05	0.000111	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.89e-05	0.000111	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—schizophrenia	2.88e-05	0.000111	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GSK3B—schizophrenia	2.87e-05	0.00011	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB3—schizophrenia	2.85e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NPY—schizophrenia	2.83e-05	0.000109	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH4—schizophrenia	2.83e-05	0.000109	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ATP2A2—schizophrenia	2.83e-05	0.000109	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—COMT—schizophrenia	2.77e-05	0.000106	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—schizophrenia	2.75e-05	0.000106	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—schizophrenia	2.75e-05	0.000106	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOA—schizophrenia	2.75e-05	0.000106	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	2.73e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1B—schizophrenia	2.73e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OXT—schizophrenia	2.73e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	2.73e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLCH2—schizophrenia	2.72e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	2.71e-05	0.000104	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—schizophrenia	2.7e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRG1—schizophrenia	2.67e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MEF2C—schizophrenia	2.64e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1A—schizophrenia	2.63e-05	0.000101	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—APOA1—schizophrenia	2.59e-05	9.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NPS—schizophrenia	2.59e-05	9.94e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NDST3—schizophrenia	2.56e-05	9.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—YWHAZ—schizophrenia	2.56e-05	9.82e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—schizophrenia	2.55e-05	9.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2C—schizophrenia	2.54e-05	9.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD1—schizophrenia	2.54e-05	9.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—schizophrenia	2.53e-05	9.72e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOA1—schizophrenia	2.52e-05	9.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB3—schizophrenia	2.5e-05	9.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	2.49e-05	9.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EP300—schizophrenia	2.48e-05	9.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK2—schizophrenia	2.47e-05	9.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD3—schizophrenia	2.46e-05	9.44e-05	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.44e-05	9.38e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ESR1—schizophrenia	2.44e-05	9.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC27A5—schizophrenia	2.42e-05	9.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACSL6—schizophrenia	2.42e-05	9.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD4—schizophrenia	2.38e-05	9.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.37e-05	9.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PRODH—schizophrenia	2.37e-05	9.1e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—schizophrenia	2.32e-05	8.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DAO—schizophrenia	2.31e-05	8.89e-05	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—schizophrenia	2.28e-05	8.78e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CNR1—schizophrenia	2.28e-05	8.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD2—schizophrenia	2.22e-05	8.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR7—schizophrenia	2.22e-05	8.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PNP—schizophrenia	2.22e-05	8.52e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GSK3B—schizophrenia	2.21e-05	8.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EP300—schizophrenia	2.19e-05	8.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRL—schizophrenia	2.1e-05	8.06e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—schizophrenia	2.07e-05	7.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NDUFV2—schizophrenia	2.06e-05	7.92e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EP300—schizophrenia	2.03e-05	7.79e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—schizophrenia	2.01e-05	7.73e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—S100B—schizophrenia	1.95e-05	7.51e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIP4K2A—schizophrenia	1.94e-05	7.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—GSK3B—schizophrenia	1.94e-05	7.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MPC2—schizophrenia	1.93e-05	7.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FOS—schizophrenia	1.92e-05	7.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	1.92e-05	7.39e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—schizophrenia	1.9e-05	7.29e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EP300—schizophrenia	1.89e-05	7.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB4—schizophrenia	1.87e-05	7.19e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCH2—schizophrenia	1.79e-05	6.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLA2G4A—schizophrenia	1.76e-05	6.76e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP26B1—schizophrenia	1.75e-05	6.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRG1—schizophrenia	1.73e-05	6.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MEF2C—schizophrenia	1.71e-05	6.57e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NDST3—schizophrenia	1.69e-05	6.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—YWHAZ—schizophrenia	1.65e-05	6.35e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—schizophrenia	1.64e-05	6.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB3—schizophrenia	1.62e-05	6.21e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACSL6—schizophrenia	1.6e-05	6.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC27A5—schizophrenia	1.6e-05	6.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH1—schizophrenia	1.56e-05	6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCLM—schizophrenia	1.56e-05	6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—schizophrenia	1.56e-05	5.98e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DAO—schizophrenia	1.52e-05	5.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—schizophrenia	1.5e-05	5.76e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—schizophrenia	1.49e-05	5.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.47e-05	5.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PRKD1—schizophrenia	1.47e-05	5.64e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PNP—schizophrenia	1.46e-05	5.62e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EP300—schizophrenia	1.46e-05	5.59e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—schizophrenia	1.45e-05	5.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—schizophrenia	1.45e-05	5.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOA1—schizophrenia	1.43e-05	5.49e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—schizophrenia	1.43e-05	5.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ESR1—schizophrenia	1.38e-05	5.31e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.36e-05	5.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—schizophrenia	1.32e-05	5.08e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.28e-05	4.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EP300—schizophrenia	1.27e-05	4.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—schizophrenia	1.27e-05	4.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GSK3B—schizophrenia	1.25e-05	4.81e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GAPDH—schizophrenia	1.23e-05	4.71e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—schizophrenia	1.23e-05	4.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CLOCK—schizophrenia	1.21e-05	4.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.21e-05	4.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.2e-05	4.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH2—schizophrenia	1.18e-05	4.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNB2—schizophrenia	1.18e-05	4.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DPYD—schizophrenia	1.16e-05	4.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.16e-05	4.44e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—schizophrenia	1.14e-05	4.39e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNA1C—schizophrenia	1.08e-05	4.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3C2A—schizophrenia	1.05e-05	4.05e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—schizophrenia	1.04e-05	4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH1—schizophrenia	1.03e-05	3.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCLM—schizophrenia	1.03e-05	3.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PRKD1—schizophrenia	9.68e-06	3.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2D6—schizophrenia	9.46e-06	3.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SNAP25—schizophrenia	9.46e-06	3.64e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—schizophrenia	8.79e-06	3.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A2—schizophrenia	8.56e-06	3.29e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TH—schizophrenia	8.43e-06	3.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EP300—schizophrenia	8.24e-06	3.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GAPDH—schizophrenia	8.08e-06	3.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CLOCK—schizophrenia	8.01e-06	3.08e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH2—schizophrenia	7.81e-06	3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNB2—schizophrenia	7.81e-06	3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—schizophrenia	7.7e-06	2.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DPYD—schizophrenia	7.68e-06	2.95e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COMT—schizophrenia	7.17e-06	2.76e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNA1C—schizophrenia	7.14e-06	2.74e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—schizophrenia	7.14e-06	2.74e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOA—schizophrenia	7.12e-06	2.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3C2A—schizophrenia	6.96e-06	2.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.9e-06	2.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—schizophrenia	6.76e-06	2.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—schizophrenia	6.56e-06	2.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G4A—schizophrenia	6.56e-06	2.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2D6—schizophrenia	6.24e-06	2.4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SNAP25—schizophrenia	6.24e-06	2.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—schizophrenia	5.9e-06	2.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—schizophrenia	5.8e-06	2.23e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A2—schizophrenia	5.64e-06	2.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TH—schizophrenia	5.56e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—schizophrenia	5.4e-06	2.07e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA1—schizophrenia	5.33e-06	2.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—schizophrenia	4.98e-06	1.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COMT—schizophrenia	4.73e-06	1.82e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—schizophrenia	4.71e-06	1.81e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOA—schizophrenia	4.7e-06	1.81e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—schizophrenia	4.46e-06	1.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—schizophrenia	4.33e-06	1.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G4A—schizophrenia	4.33e-06	1.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—schizophrenia	3.82e-06	1.47e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—schizophrenia	3.56e-06	1.37e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA1—schizophrenia	3.52e-06	1.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EP300—schizophrenia	3.08e-06	1.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EP300—schizophrenia	2.03e-06	7.8e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—schizophrenia	1.86e-06	7.14e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—schizophrenia	1.23e-06	4.71e-06	CbGpPWpGaD
